Imugene Ltd
16/4/03
Has acquired the balance of the outstanding share capital in its production animal subsidiary, VectoGen Ltd. The consideration for the acquisition comprises the issue of 14,745,433 new ordinary Imugene shares and the issue of 8,872 convertible preference shares. On settlement of the acquisition agreements with the various VectoGen shareholders, Imugene will increase its ownership from 40% to 100% of VectoGen.
Safe Effect Technologies Ltd
16/4/03
Has now entered into a Share Acquisition Agreement with KPN Group for the acquisition from KPN of a controlling interest of 51% of Siam Adler Co Ltd for cash consideration of US$1.7 million.